4
Changes in Ownership
Aligos Therapeutics, Inc. Filed Acc 0001567619-20-020624
Options or other derivatives
- See Remarks acquired 176,237 shares (grant or award)
From the SEC's structured data for this filing
Aligos Therapeutics, Inc. Filed Acc 0001567619-20-020624
Options or other derivatives
From the SEC's structured data for this filing
Connection lost
Reconnecting…
Cite Filings isn't responding
Reconnecting…